References and Notes
1a
Wall ME.
Wani MC.
Cook CE.
Palmer KH.
McPhail AT.
Sim GA.
J.
Am. Chem. Soc.
1966,
88:
3888
1b
Govindachari TR.
Viswanathan N.
Indian.
J. Chem.
1972,
10:
453
1c
Ma ZZ.
Hano Y.
Nomura T.
Chen YJ.
Heterocycles
1997,
46:
541
1d
Ma ZZ.
Hano Y.
Nomura T.
Chen YJ.
Heterocycles
1999,
51:
1883
2
Ali MM.
Tasneem KC.
Rajanna PK.
.
Synlett
2001,
251
3a
Amin AH.
Mehta DR.
Samarth SG.
Prog. Drug Res.
1970,
14:
218
3b
Johne S.
Prog.
Drug Res.
1982,
26:
259
4
Cagir A.
Jones SH.
Gao R.
Eisenhauer BM.
Hecht SM.
J. Am. Chem. Soc.
2003,
125:
13628
5a
Zhao H.
Lee C.
Sai P.
Choe YH.
Boro M.
Pendri A.
Guan S.
Greenwald RB.
J. Org. Chem.
2000,
65:
4601
5b
Fassberg J.
Stella VJ.
J. Pharm. Sci.
1992,
81:
676
5c
Burke TG.
Mi Z.
Anal. Biochem.
1993,
212:
285
5d
Burke TG.
Mi Z.
J. Med. Chem.
1994,
37:
40
6a
Suresh Babu M.
Raghunadh A.
Anil Kumar N.
Syam Kumar UK.
Vasu Dev R.
Dubey PK.
J. Heterocycl.
Chem.
2010,
47: in
press
6b
Sawada S.
Okajima S.
Aiyama R.
Nokota K.
Furuta T.
Yokokura T.
Sugino E.
Yamaguchi K.
Miyasaka T.
Chem.
Pharm. Bull.
1991,
39:
1446
6c
Kingsbury WD.
Boehm JC.
Jacas DR.
Holden KG.
Hecht SM.
Gallagher G.
Caranfa MJ.
McCabe FL.
Faucette LF.
Johnson
RP.
Hertzberg RP.
J.
Med. Chem.
1991,
34:
98
6d Subrahmanyam D, Venkateswarlu A, Sarma VM, Sastry TVRS, Krishna CV, and Madabhushi S. inventors; US 6177439 B1.
6e
Subrahmanyam D.
Sarma VM.
Venkateswarlu A.
Sastry TVRS.
Srinivas ASSV.
Krishna CV.
Deevi DS.
Kumar SA.
Babu MJ.
Damodaran NK.
Bioorg. Med. Chem.
Lett.
2000,
10:
369
6f
Subrahmanyam D.
Venkateswarlu A.
Venkateswarao K.
Sastry TVRS.
Vandana G.
Kumar SA.
Bioorg. Med.
Chem. Lett.
1999,
9:
1633
6g
Kim D.-K.
Lee N.
Mini Rev. Med. Chem.
2002,
2:
611
6h
Hatefi A.
Amsden B.
Pharm. Res.
2002,
19:
1389
7a
Servais A.
Azzouz M.
Lopes D.
Courillon C.
Malacria M.
Angew. Chem. Int. Ed.
2007,
46:
576
7b
Beaume A.
Courillon C.
Derat E.
Malacria M.
Chem. Eur. J.
2008,
16:
1228
8
Twin H.
Batey R.
Org. Lett.
2004,
6:
4913
9a
Nacro K.
Zha CC.
Guzzo PR.
Herr J.
Peace D.
Friedrich TD.
Bioorg.
Med. Chem.
2007,
13:
4237
9b
Harayama T.
Hori A.
Serban G.
Morikami Y.
Matsumoto T.
Abe H.
Takeuchi Y.
Tetrahedron
2004,
60:
10645
9c
Mason JJ.
Bergman J.
Org. Biomol.
Chem.
2007,
5:
2486
9d
Mhaske SB.
Argade NP.
J.
Org. Chem.
2004,
69:
4563
9e
Chavan SP.
Sivappa R.
Tetrahedron
2004,
60:
9931
9f
Mhaske SB.
Argade
PN.
J.
Org. Chem.
2004,
69:
4563
10
Zhou H.-B.
Liu G.-S.
Yao Z.-J.
J.
Org. Chem.
2007,
73:
6270
11
Sridharan V.
Ribelles P.
Ramos T.
Menendez JC.
J. Org.
Chem.
2009,
74:
5715
12a
Baruah B.
Bhuyan JP.
Tetrahedron
2009,
65:
7099
12b
Baruah B.
Deb ML.
Bhuyan PJ.
Synlett
2007,
1873
13a
Jana GP.
Ghorai BK.
Tetrahedron
2007,
63:
12015
13b
Chavan SP.
Pasupathy K.
Sivappa R.
Venkatraman MS.
Synth.
Commun
. 2004,
34:
3099
13c
Chavan SP.
Sivappa R.
Tetrahedron
Lett.
2004,
45:
3113
14
Takao S.
Kazutoshi O.
J. Chem. Soc., Perkin Trans.
1
1999,
16:
2323
15 To a suspension of 2-cyanoquinoline-3-acetal
(9, 1 g, 0.004 mol, 1 equiv) in AcOH (10
mL), methyl anthranilate (0.7 g, 0.005 mol, 1.05 equiv) was added,
and the reaction mixture was heated to reflux for a period of 12-14
h. The reaction mass was then cooled, the precipitated product was
filtered off, and further purified by column chromatography using EtOAc
and hexane (7:3) to yield the lutonin B. The filtrate was diluted
with H2O, and extracted with EtOAc, and dried. Concentration
and purification by column chromatography yielded 11.
16 To a suspension of cyanoaldehyde (1
g, 0.5 mmol, 1 equiv) in AcOH (10 mL) and Ac2O (0.2 mL),
methyl anthranilate (0.554 g, 0.71 mmol, 1.5 equiv) was added, and
the reaction mixture was heated to reflux for a period of 12-14
h. The reaction mass was then cooled to r.t., and precipitated product
was filtered off. The mother liquor was then diluted with H2O,
and extracted with EtOAc. The precipitated product mixture and the
EtOAc extracts were combined together, concentrated under vacuum.
The product was then purified by column chromatography using EtOAc
and hexane (7:3), and pure luotonin B was isolated as white to off-white
solid in 0.890 g, 54% of yield. Also 12% of 11 was also isolated from the column.
17
Methyl-2-(11-oxo-11,13-dihydroquinolino[2′,3′:3,4]-pyrrolo[2,1-
b
]quinazolin-13-yl)amino
benzoate (11)
Yield 20%; mp 312-314 ˚C. ¹H
NMR (400 MHz, CDCl3):
δ = 3.80
(s, 3 H), 6.77 (t, J = 7.2
Hz, 1 H), 7.26 (s, 1 H), 7.27 (s, 1 H), 7.35 (t, J = 7.6
Hz, 1 H), 7.52 (t, J = 6.8
Hz, 1 H), 7.69 (t, J = 7.6
Hz, 1 H), 7.80-7.97 (m, 4 H), 8.1 (d, J = 8.0 Hz,
1 H), 8.34 (dd, J = 1.6,
7.8 Hz, 1 H), 8.48 (s, 1 H) 8.52 (d, J = 8.8
Hz, 1 H), 8.85 (d, J = 9.6
Hz, 1 H). ¹³C NMR (400 MHz, CDCl3): δ = 51.8,
68.4, 112, 113.6, 117.6, 122.4, 126.7, 127.6, 128.4, 128.6, 128.8,
129.1, 130.8, 131.2, 131.7, 132.2, 132.6, 134.4, 134.6, 148.0, 149.0,
150.0, 150.4, 151.4, 160.6, 168.9. MS: m/z (%) = 435 [M + 1], 302.2,
137.1. Anal Calcd for C26H18N4O3:
C, 71.88; H, 4.18; N, 12.90. Found: C, 71.86; H, 4.15; N, 12.87.
18 Luotonin B (2)
Yield
0.89 g (54%); mp 273-275 ˚C.
IR (KBr): 1028, 1266, 1449, 2041, 2945, cm-¹. ¹H
NMR (400 MHz, DMSO-d
6):
δ = 6.98
(d, J = 8.4
Hz, 1 H), 7.62-7.66 (m, 2 H), 7.78 (t, J = 7.2
Hz, 1 H), 7.92-7.96 (m, 3 H), 8.23 (d, J = 8.0
Hz, 1 H), 8.28 (dd, J = 3.6
Hz, 8.4 Hz, 2 H), 8.80 (s, 1 H). ¹³C NMR
(400 MHz, DMSO-d
6): δ = 80.5,
122.2, 126.1, 127.5, 128.2, 128.3, 128.7, 128.8, 129.6, 131.0, 132.8,
133.8, 134.7, 148.7, 149.1, 150.3, 151.5, 159.4. MS m/z (%) = 302.1 [M + 1],
246.2, 150.1. Anal Calcd for C18H11N3O2:
C, 71.75; H, 3.68; N, 13.95. Found: C, 71.77; H, 3.69; N, 13.90.
19 To a solution of luotonin B (0.35
g, 0.16 mol, 1 equiv) in MeOH (3.5 mL, 10 V), Indion resin (0.1
g, 0.01 mmol, 0.1 equiv) was added, and the reaction mixture was
heated at 55 ˚C for a period of 6-7 h.
The reaction mixture was then cooled, and the resin was filtered
off and washed with MeOH (1 mL). The filtrate was concentrated under
reduced pressure, and purified on a filter column using EtOAc-hexane
(30:70). The product was isolated as a white to off-white solid
in 80% (0.29 g) yield.
Luotonin
E
Yield 0.29 g (80%).; mp 222-224 ˚C.
IR (KBr): 1047, 1237, 1300, 1375, 1730, 2985 cm-¹. ¹H
NMR (400 MHz, CDCl3): δ = 3.60 (s,
3 H), 6.90 (s, 1 H), 7.58 (dt, J = 0.8,
7.6, 11.2 Hz, 1 H), 7.71 (t, J = 6.8
Hz, 1 H), 7.82-7.88 (m, 2 H), 7.99 (d, J = 8.4
Hz, 1 H), 8.09 (d, J = 8.0
Hz, 1 H) 8.41 (dd, J = 1.2, 8.0
Hz, 1 H), 8.47 (d, J = 8.4
Hz, 1 H), 8.5 (s, 1 H). ¹³C NMR (400
MHz, CDCl3): δ = 56.3, 87.0, 122.2,
126.8, 127.8, 128.4, 128.6, 128.8, 130.0, 130.7, 131.3, 133.0, 134.8, 148.9,
150.4, 151.3, 160.7. MS: m/z (%) = 316.2 [M + 1], 279.2,
130.2. Anal Calcd for C19H13N3O2:
C, 72.37; H, 4.16; N, 13.33. Found: C, 72.34; H, 4.15; N, 13.35.
20
Tetrahydroluotonin
A (20)
Yield 190 mg (50%); mp 191-193 ˚C. ¹H
NMR (400 MHz, CDCl3): δ = 2.57 (dd, J = 8.0, 14.8
Hz, 1 H), 2.95-3.06 (m, 2 H), 4.03 (dd, J = 4.0,
12.0 Hz, 1 H), 4.33 (dd, J = 6.8,
12 Hz, 1 H), 4.66 (s, 1 H), 4.81 (dd, J = 3.2,
7.8 Hz, 1 H), 6.65 (d, J = 6.7
Hz, 1 H), 6.70 (dd, J = 0.4,
10.6 Hz, 1 H), 7.01 (m, 2 H) 7.45 (m, 1 H), 7.72-7.80 (m,
2 H), 8.29 (d, J = 8.4
Hz, 1 H). ¹³C NMR (400 MHz, CDCl3): δ = 28.5,
31.6, 49.7, 57.6, 114.3, 118.6, 120.0, 121.1, 126.4, 126.7, 127.1,
127.6, 128.8, 134.2, 142.6, 149.2, 159.5, 160.9. MS: m/z (%) = 435 [M + 1],
290.2, 202.2, 186.2. Anal Calcd for C18H15N3O:
C, 74.72; H, 5.23; N, 14.52. Found: C, 74.70; H, 5.21; N, 14.57.